Simvasterol

Quick links to important sections

Simvasterol

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simvasterol

Property Description
Active Ingredient Simvastatin
Form Oral Tablet (film-coated)
Pharmacological Class Statin (HMG-CoA Reductase Inhibitor)
Common Purpose Lipid-lowering therapy
Origin Semi-Synthetic

What Type of Medicine is Simvasterol?

Simvasterol is a prescription-only medication that contains the single active ingredient Simvastatin. It is categorized as an antihyperlipidemic agent, a class of drugs designed to manage abnormal levels of lipids in the bloodstream. Specifically, Simvasterol belongs to the statin pharmacological group, chemically known as an HMG-CoA reductase inhibitor. Statins are clinically recognized for their effectiveness in addressing dyslipidemia.

Simvasterol’s General Purpose and Mechanism Group

The general objective of Simvasterol is to serve as a foundational lipid-lowering therapy aimed at regulating cholesterol concentrations. It works by acting as a competitive inhibitor of the enzyme HMG-CoA reductase, which is the necessary rate-limiting step for the body's internal production of cholesterol in the liver. By disrupting this synthesis process, the medication helps to reduce the circulating levels of low-density lipoprotein cholesterol (LDL-C), often termed "bad cholesterol." This pharmacological class is considered a standard of care for lowering LDL-C and is a primary tool for managing high cholesterol.

Dosage Form and Route

Simvasterol is supplied as a single-ingredient product in the form of a solid, film-coated oral tablet. This specific film-coating is a feature intended to ensure ease of swallowing. This formulation facilitates the systemic absorption required for the active compound, Simvastatin, to reach the liver and exert its targeted enzymatic action via the oral route of administration. The semi-synthetic origin of Simvastatin ensures its consistency and high purity in this specific tablet formulation.

Regulatory References

  1. WHO Essential Medicines List - Simvastatin
  2. Statins: MedlinePlus Overview

What side effects are possible with Simvasterol?

Possible Side Effects and Safety Information

Simvasterol (simvastatin) has an officially documented safety profile, with potential side effects classified by frequency and grouped according to the body systems affected, consistent with regulatory standards.


General Adverse Reactions and Frequency Classification

The most common adverse reactions documented in official labeling typically involve the gastrointestinal and nervous systems, and include headache, upper respiratory infection, abdominal pain, constipation, and nausea. Effects classified as uncommon may include myalgia (muscle pain), dizziness, rash, and pruritus (itching). Rare reports describe more severe reactions within the Immune System and Hepatobiliary Disorders.

Serious Adverse Reactions and Systemic Patterns

A major focus of regulatory safety is the risk of Musculoskeletal Disorders. Simvastatin is officially associated with the potential for myopathy, which can progress to the severe condition of rhabdomyolysis. This muscle breakdown can potentially lead to renal failure. Additionally, the label documents risks associated with the liver, including reports of hepatitis, jaundice, and rare cases of fatal and non-fatal hepatic failure. Serious, though rare, hypersensitivity reactions like angioedema and anaphylaxis are also officially noted.

Safety Considerations for Specific Populations and Contexts

Official labels identify specific groups with potentially increased risk for muscle-related adverse effects, including patients 65 years of age and older and those with existing renal impairment. The medication is generally not recommended during pregnancy due to the potential for fetal harm. Safety notes indicate that the risk for myopathy is documented as being highest during the first 12 months of treatment. The presence of active liver disease is a formal contraindication for use, and consumption of large quantities of grapefruit juice is noted to increase the risk of adverse effects.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Simvasterol (Simvastatin) is structured around limited clinical experience and mandated emergency actions. All reported human cases of Simvastatin overdosage have resulted in full recovery without sequelae.

Documented Overdose Findings

Classification Official Regulatory Statement
Symptom Manifestation No specific diagnostic signs were officially observed in reported human cases of overdosage.
Life-Threatening Outcomes Overdosage generally resulted in full recovery without sequelae in reported cases.

Emergency Actions Mandated by Regulation

Immediate medical attention is required to initiate necessary care. The official prescribing information mandates symptomatic and supportive treatment in the event of overdosage. Management protocols specify that haemodialysis is not expected to significantly enhance clearance of the active substance due to its extensive protein binding. This guidance reflects the procedural limitations and focuses treatment on supportive measures. No specific antidote for Simvasterol overdosage is documented in official regulatory labeling.

Therapeutic Uses of Simvasterol

What Simvasterol Treats: Main Uses and Benefits


Simvasterol is used for patients in situations involving specific profiles related to the body's lipids and high cardiovascular risk.

The medication is commonly used to address the condition of dyslipidemia—which refers to abnormally high concentrations of key fats in the blood, specifically high levels of LDL cholesterol and triglycerides. It is also utilized in high-risk scenarios, such as for patients with established conditions like coronary artery disease or a history of cerebrovascular disease.

The primary therapeutic area involves long-term support, where the medication assists in addressing this pathological lipid burden. As part of a comprehensive management strategy, it supports the patient by helping to manage factors related to high cardiovascular risk.

The medication is applied in addressing conditions associated with episodes of cardiovascular disease and its long-term management.

Quick Fact: Supportive Management for High Risk

Simvasterol assists with maintaining physiological stability and is part of the management strategy in situations where high LDL-C and triglycerides contribute to cardiovascular strain.

Regulatory References

  1. U.S. National Library of Medicine (NIH) DailyMed

Eligibility and Restrictions for Use

Simvasterol (Simvastatin) is an oral medication generally prescribed to adults and children over 10 years of age to lower cholesterol and reduce the risk of cardiovascular events, as part of a comprehensive treatment plan including diet and exercise.

Simvasterol is not appropriate for everyone and is contraindicated (should not be used) in certain circumstances to prevent serious harm. You should not take Simvasterol if you have:

  • Active liver disease or unexplained, persistent elevated liver enzymes.
  • A known allergy to simvastatin or any other ingredient in the medication.
  • Are pregnant, planning to become pregnant, or breastfeeding, as statins may harm a developing fetus or infant.

Important Precautions and Drug Interactions

Careful consideration and monitoring are required if you have a history of liver disease, heavy alcohol consumption, or kidney problems. Additionally, the risk of muscle side effects (myopathy) is increased if you have hypothyroidism (underactive thyroid) that is not well-controlled, or a history of muscle disorders.

Simvasterol's effectiveness and safety can be significantly impacted by interactions with other medications. The risk of serious muscle toxicity is especially high when Simvasterol is taken concurrently with certain drugs, including some antifungals, antibiotics, HIV/Hepatitis C antivirals, certain heart medications (e.g., Amiodarone, Verapamil), Gemfibrozil, and large quantities of grapefruit juice.

What should I know about interactions with other medicines?

Simvasterol's official interaction profile is defined primarily by its pharmacokinetic constraints, which govern the risk of significantly increased systemic exposure of the active Simvastatin acid. This exposure increase, resulting from inhibition of CYP3A4 metabolism and the OATP1B1 transport protein, raises the formally documented risk of myopathy and rhabdomyolysis.


Regulatory-Defined Restrictions and Classifications

Numerous medicinal products are classified based on their interaction severity. Contraindicated combinations include strong CYP3A4 inhibitors (such as certain azole antifungals and macrolide antibiotics), Gemfibrozil, Cyclosporine, and Danazol, which must not be co-administered. For other interacting agents, such as Verapamil, Diltiazem, Amiodarone, and Amlodipine, the regulatory label imposes specific dose restrictions to mitigate the elevated risk.


Specific Interaction Notes

Pharmacodynamic interactions are also documented. Co-administration with Coumarin Anticoagulants is officially noted to potentiate the anticoagulant effect, increasing the International Normalized Ratio (INR). For certain substances, mandatory time constraints apply: Simvasterol must be administered at least two hours before or four hours after Bile Acid Sequestrants. The official label advises against consuming large quantities of Grapefruit Juice (over one quart daily), which can raise plasma levels. Furthermore, the risk of myopathy is documented as heightened in Chinese patients taking high-dose Niacin (ge 1 g/day).

Mechanism of Action

How Simvastatin Works

Simvastatin is metabolized in the liver to its active form, which functions as a competitive inhibitor of the enzyme HMG-CoA reductase. This enzyme is the rate-limiting step in the mevalonate pathway for cholesterol synthesis within hepatocytes.

Inhibition of this enzyme directly restricts the cell's ability to produce cholesterol. This reduction in intracellular cholesterol triggers a compensatory cellular feedback mechanism, leading to the upregulation of Low-Density Lipoprotein (LDL) receptors on the liver cell surface.

The increased number of functional LDL receptors enhances the liver's capacity to bind, capture, and remove circulating LDL particles from the bloodstream. This combined action of reduced internal production and enhanced external clearance results in a fundamental shift in systemic lipid homeostasis, producing a reduction in LDL cholesterol and other lipoproteins.

Dosage and Administration Information

Administration Guidelines for Simvasterol

This section outlines the use of this medicine based on standard prescribing information and therapeutic protocols.

Feature Guideline
Route of Administration Oral
Dosing Schedule Once daily, as a single dose in the evening
Standard Adult Dose Recommended range is typically 20 mg to 40 mg once daily.
Maximum Daily Dose Generally restricted to 40 mg per day for new patients. The 80 mg dose is strictly limited to patients who have been taking it chronically (e.g., 12 months or more) without muscle toxicity.
Timing in Relation to Meals May be taken with or without food

Procedural and Population-Specific Instructions

  • Tablet Ingestion: The tablet must be swallowed whole with liquid and should not be crushed or chewed.
  • Dose Adjustment: Dosage changes, if required, should be made at intervals of not less than 4 weeks after initiation or previous adjustment, based on monitoring results.
  • Renal Impairment: For patients with severe renal insufficiency (creatinine clearance < 30 mL/min), a lower starting dose, typically 5 mg once daily, is recommended, requiring cautious implementation.
  • Adolescent Use: For pediatric patients (e.g., ages 10 to 17 years) with specific conditions, the recommended range is 10 mg to 40 mg once daily in the evening.
  • Missed Dose: If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular schedule. Do not take two doses to make up for a missed one.

These instructions establish the standardized, long-term oral treatment protocol, defining the precise time of administration and the minimum time required between dose titrations.

Recent Clinical Evidence

Research evidence / Overview of studies for Simvasterol

Simvasterol was studied as a compound categorized for use in managing lipids primarily through large, organized clinical trials and subsequent analyses. This research base is used by regulators to understand what the compound was studied for and what data show patterns related to its use in specific patient groups. The evidence contributes to the broader research available for high cardiovascular risk.


Evidence for use in Managing High Cardiovascular Risk

The initial and most extensive research was conducted in populations determined to be at high cardiovascular risk. The main research design studies utilized was the Randomized Controlled Trial (RCT), where participants were randomly assigned to a study group to receive either Simvasterol or a placebo over a defined time interval.

These large-scale RCTs was evaluated in adults who either had established Atherosclerotic Cardiovascular Disease (ASCVD) or were considered at high risk for a first event. Studies monitored hard clinical endpoints, which included the time to first occurrence of a major coronary event (e.g., myocardial infarction or the need for artery revascularization) and the incidence of cerebrovascular events (stroke). All-cause mortality was also observed in these studies.

When these extensive trial data were synthesized into meta-analyses, data show patterns related to the recorded frequency of these events across the observed populations. However, statistical heterogeneity (variability in results) was observed in some studies when they examined the outcome of all-cause mortality, meaning the patterns were mixed across different research groups.


Evidence for Lipid-Lowering Effects (Dyslipidemia)

Simvasterol was studied to observe patterns related to the levels of fats, or lipids, in the bloodstream. The primary research focus here was evaluated in studies tracking key biomarker shifts. These studies research examined how concentrations of Low-Density Lipoprotein Cholesterol (LDL-C) and triglycerides changed from the start of the study period.

The research describes changes measured during the study period in these specific lipid markers. These findings provide context regarding the measured shifts in these levels, which is the research basis for its regulatory designation.


Long-Term Studies and Follow-up Duration

Clinical trials for Simvasterol typically followed participants for intermediate to long-term periods, with most key trials assessing primary outcomes over four to five years. Research explored short-term symptom changes but also monitored long-term outcomes.

Beyond the trial completion, long-term outcomes for all populations are not fully characterized. However, extended post-trial follow-up data was associated with further observation in some cohorts for nine years or more.

Key Studies & References

  1. Simvastatin Tablets Official Label (FDA Approved Drug Products)
  2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Frequently Asked Questions (FAQ)

Common questions about Simvasterol (FAQ)

Q: How quickly does Simvasterol usually start working?

Regulatory documents state that the peak concentration of the active drug in the blood is typically measured within a few hours of administration. However, the effect on LDL-C (often called 'bad cholesterol') is measured by healthcare professionals after about six weeks of treatment to assess whether the medication is having the desired effect.

Q: Do I need to take Simvasterol forever, or can I stop when I feel better?

Official regulatory information describes the conditions Simvasterol treats as a chronic process. The drug is used as part of a long-term treatment plan alongside diet and exercise. Regulatory documents indicate that patients are generally not advised to discontinue the medication without guidance from a healthcare professional.

Q: Is it common to feel tired when first starting Simvasterol?

Fatigue or tiredness is not typically listed among the most common adverse reactions documented in official labeling, which include headache and nausea. However, regulatory updates have noted that symptoms like fatigue, weakness, or muscle pain may be reported. Concerns regarding weakness or fatigue are typically addressed by a healthcare professional.

Q: What kind of foods or drinks should people pay attention to while using Simvasterol?

Official patient counseling guides advise that people should avoid consuming large quantities of grapefruit juice, which is defined as over one quart daily. Furthermore, the label notes a documented risk of certain adverse effects for those with a history of heavy alcohol consumption.

Q: Can Simvasterol be used by older adults?

Simvasterol is generally used in adult patients. Regulatory documents specifically note that individuals 65 years of age and older have a potentially increased risk for muscle-related side effects. The use of Simvasterol in this group is managed through specific monitoring and professional review.

Q: Do other medications I'm taking make Simvasterol less effective?

Official regulatory documents indicate that the way Simvasterol is absorbed may be affected by certain other drugs. For instance, the administration of Bile Acid Sequestrants must be separated by time (at least two hours before or four hours after) from Simvasterol to avoid affecting its function.

Q: Are there any long-term effects of taking Simvasterol that people commonly discuss?

Regulatory agencies have noted that potential adverse reactions with some statin therapies, like Interstitial lung disease, have been reported, sometimes associated with long-term therapy. The label also documents the possibility of increases in blood sugar levels, specifically HbA1c and Fasting Serum Glucose, with long-term use.

Q: What happens if someone accidentally takes too much Simvasterol?

The official product label contains a section addressing Overdosage. Patient information guides describe that in cases of suspected overdose, the recommended course of action is to contact emergency medical services or the Poison Help line.

Q: Do the side effects of Simvasterol go away after the first few weeks?

Official regulatory documents indicate that the incidence of myopathy (a specific muscle injury risk) was documented as highest during the first year of treatment and decreased in subsequent years. The label does not specify the time course for the resolution of common side effects like headache or constipation.

Q: Is Simvasterol considered a high-risk medication?

The regulatory label classifies the medication's safety by frequency and seriousness, documenting the potential for serious adverse reactions such as severe muscle injury (myopathy) and severe liver issues (hepatic dysfunction). These specific risks are detailed in the Warnings and Precautions sections of the official documents.

Q: Are there alternatives to Simvasterol for people who cannot use it?

The official product label advises that for patients unable to reach their cholesterol goal on the maximum approved dose or who cannot tolerate Simvasterol, healthcare professionals should prescribe alternative LDL-C-lowering treatment(s) as necessary.

Q: Does Simvasterol affect blood sugar levels?

Regulatory warnings state that increases in HbA1c and Fasting Serum Glucose Levels have been reported with the use of Simvastatin. This means that a person's blood sugar measurements may be affected by the medication.

Q: What is the typical duration of treatment with Simvasterol?

As atherosclerosis (a condition Simvasterol is used to address) is a chronic condition, the drug is generally intended for long-term therapy as an adjunct to diet and lifestyle changes. The highest dose available is strictly limited to patients who have been taking the drug chronically (for 12 months or more) without muscle issues.

Q: Are there any specific lifestyle changes that official documents suggest alongside Simvasterol?

Official patient counseling guides state that Simvasterol should be taken along with a diet to lower cholesterol. These documents also advise lifestyle adjustments commonly recommended for high cholesterol, such as weight loss and exercise.

Q: What does it mean if Simvasterol is contraindicated?

A contraindication is a strict regulatory term indicating that the drug should not be used under certain conditions because the risk of harm clearly outweighs any potential benefit. Examples of contraindications include having active liver disease or being pregnant.

Q: If a person feels fine, why do they still need to take Simvasterol?

Simvasterol is used to reduce the risk of future cardiovascular events like heart attack and stroke. Because high cholesterol typically does not cause symptoms, patient information guides describe that the official recommendation is to continue taking the medicine as prescribed, even in the absence of symptoms.

Q: Is it true that Simvasterol can interact with herbal supplements?

While the label focuses on prescription drug interactions, patient information guides generally advise discussing all medications, including herbal supplements, with a healthcare professional before taking them with Simvasterol. This is due to the potential for interactions that could affect safety or effectiveness.

Q: Is Simvasterol available in generic form?

Simvasterol is the active ingredient Simvastatin. Simvastatin is widely available as a generic product in many global markets and is recognized on the World Health Organization’s list of Essential Medicines.

Q: Does taking Simvasterol affect driving or operating machinery?

The regulatory label notes that adverse effects like dizziness have been reported. If a patient experiences dizziness or other central nervous system effects, it may potentially affect their ability to drive or operate complex machinery.

Q: Why is it important to take Simvasterol at the same time each day?

The tablets are recommended to be taken once daily in the evening. This specific timing is based on studies showing the drug is often most effective when taken at night, as the body's natural cholesterol production tends to peak during that time when a person is resting.

Q: What should a patient do if they experience an unusual reaction to Simvasterol?

Official patient information guides outline the steps to take if an unusual reaction is experienced. These steps typically include contacting a healthcare provider immediately for unexplained muscle pain or weakness, and seeking emergency services for signs of a severe allergic reaction.

Q: Does Simvasterol interact with birth control pills?

Official regulatory documents do not specifically list oral contraceptives as interacting agents. However, because Simvasterol is contraindicated in women who are pregnant or may become pregnant, women of childbearing potential are advised to use effective contraception during treatment.

Q: What is the expected effectiveness of Simvasterol after six months of use?

Official documents define effectiveness by tracking key biomarkers, such as LDL-C concentration. The measured shifts in these lipid levels are typically observed over the study period. While the label does not promise specific results, the first professional assessment of effectiveness usually occurs after approximately six weeks of therapy.

Q: Can Simvasterol be safely used by people with kidney issues?

People with kidney issues (renal impairment) are noted in regulatory documents as a population with potentially increased risk for muscle side effects. For patients with severe kidney insufficiency, official guidelines recommend a lower starting dose, requiring cautious implementation and monitoring.

Q: What are the documented safety classifications of Simvasterol?

Simvasterol is classified by regulatory authorities based on the potential risk to an unborn child. Official warnings state that Simvasterol is contraindicated in pregnancy due to the potential for fetal harm. This means the drug is generally not used during pregnancy.

How should Simvasterol be stored and disposed of?

How to Store and Dispose of Simvasterol

Simvasterol (Simvastatin) tablets must be stored at controlled room temperature, specifically 20^circC to 25^circC (68^circF to 77^circF), as directed by regulatory labeling. The medication must be actively protected from light, moisture, and heat, and it is prohibited to keep the tablets from freezing.


For storage integrity, the tablets should be kept in a closed container and preferably in their original packaging. A mandatory safety rule requires Simvasterol to be stored out of the reach and sight of children.


Disposal must follow specific regulatory guidance: do not throw away unused or expired medicine via wastewater or household waste. Patients should consult a healthcare professional or pharmacist for instructions on how to dispose of the product according to local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Simvasterol found in:

A-Z Index: